Department of Hematology, the Fifth Medical Center of Chinese PLA General Hospital
Department of Hematology, the Fifth Medical Center of Chinese PLA General Hospital
Beijing, China3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Venetoclax-containing Therapy Combined With Microtransplant for Intermediate-risk and Higher MDS | Hemic and Lymphatic Diseases, bone marrow disorder, hematologic disorder, myelodysplastic syndrome | Recruiting | Phase 2 | 2026-10-09 | NCT07238686 | |
| Phase 1 Study of Chemotherapy Plus HLA-mismatched GPBMC Infusion Bridging to Allo-HSCT for R/R Leukemia | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, hematologic disorder, leukemia, neoplasm | Recruiting | Phase 1 | 2025-12-22 | NCT07297173 | |
| Venetoclax-containing Therapy Combined With Microtransplant for Newly Diagnosed AML | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Recruiting | Phase 2 | 2025-07-28 | NCT07078591 |